Rezivertinib
Rezivertinib (BPI-7711) is an orally available, selective and potent inhibitor of tyrosine kinase (EGFR) with antitumor activity for central nervous system disorders.
Product Specifications
CAS Number
1835667-12-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
486.57
Molecular Formula
C27H30N6O3
Notes
Research use only, not for human use.
Receptor
EGFR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IRTAMSCD4530F11CFITC25UG 25 µg
Anti Mouse CD45 Flow Cytometry Monoclonal Clone 30F11 FITC 25ug
Sign In for Pricing
View Details 
224275-01 50 µL
MRP-S27 (MRPS27, Mitochondrial Ribosomal Protein S27, FLJ21764, FLJ23348, KIAA0264, MRP-S27) discontinued
Sign In for Pricing
View Details 224275-02 100 µL
MRP-S27 (MRPS27, Mitochondrial Ribosomal Protein S27, FLJ21764, FLJ23348, KIAA0264, MRP-S27) discontinued
Sign In for Pricing
View Details K7441805 3x 1.0 µg
Mrgprx1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 